CNTX icon

Context Therapeutics

39 hedge funds and large institutions have $45M invested in Context Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 8 closing their positions.

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VCIM
26
Velan Capital Investment Management
Georgia
$65.5K 100,000 +10,000 +11%
CHAM
27
Clear Harbor Asset Management
Connecticut
$37.9K 57,804
GS
28
GTS Securities
New York
$28.9K 44,176 +44,176 New
Cerity Partners
29
Cerity Partners
New York
$13.1K 20,000 +10,000 +100%
CC
30
Caxton Corporation
New Jersey
$12.1K 18,403
Millennium Management
31
Millennium Management
New York
$11.2K 17,067 -31,604 -65%
Osaic Holdings
32
Osaic Holdings
Arizona
$10.5K 10,000
CWM
33
Congress Wealth Management
Massachusetts
$9.83K 15,000
TRCT
34
Tower Research Capital (TRC)
New York
$4.86K 7,414 -5,890 -44%
Morgan Stanley
35
Morgan Stanley
New York
$2.29K 3,500 +3,400 +3,400%
NFSG
36
Newbridge Financial Services Group
Florida
$1.31K 2,000 +2,000 New
Bank of America
37
Bank of America
North Carolina
$356 543 +99 +22%
UBS Group
38
UBS Group
Switzerland
$242 370 -62 -14%
SS
39
SBI Securities
Japan
$74 113
ABG
40
Ally Bridge Group
New York
-1,157,448 Closed
AI
41
Allostery Investments
Connecticut
-950,166 Closed
SC
42
Shay Capital
New York
-189,853 Closed
UOC
43
UBS O'Connor
Illinois
-67,631 Closed
LCM
44
Landscape Capital Management
New Jersey
-41,216 Closed
XT
45
XTX Topco
Cayman Islands
-15,673 Closed
BT
46
Banque Transatlantique
France
-1,800 Closed
JPMorgan Chase & Co
47
JPMorgan Chase & Co
New York
-80 Closed